亚太药业: 半年度非经营性资金占用及其他关联资金往来情况汇总表

Group 1 - Zhejiang Apac Pharmaceutical Co., Ltd. reported non-operating fund occupation by related parties, with a total of 7,157.81 million yuan as of June 2025 [1][2] - The company has a significant amount of receivables from its wholly-owned subsidiaries, including Shaoxing Yatai Pharmaceutical Co., Ltd. and Shaoxing Yatai Medical Technology Co., Ltd., amounting to 7,007.81 million yuan and 150.00 million yuan respectively [1][2] - The total amount of non-operating fund occupation is expected to be repaid, with a cumulative repayment of 7,014.87 million yuan noted [2] Group 2 - The company has engaged in operational transactions with related parties, including management fees paid to Ningbo Dadi Chemical Environmental Protection Co., Ltd., totaling 6.80 million yuan [2] - The financial data indicates a stable relationship with its subsidiaries, as evidenced by the ongoing transactions and receivables [1][2] - The company’s financial management is overseen by its legal representative and accounting personnel, ensuring compliance and accuracy in financial reporting [2]